Analyze Diet
American journal of epidemiology1971; 93(3); 194-205; doi: 10.1093/oxfordjournals.aje.a121246

Experimental infection of horses with three strains of Venezuelan equine encephalomyelitis virus. I. Clinical and virological studies.

Abstract: Henderson, B. E., W. A. Chappell, J. G. Johnston, Jr. and W. D. Sudia (CDC, Atlanta, Ga. 30333). Experimental Infection of horses with three strains of Venezuelan equine encephalomyelitis virus. I. Clinical and virological studies. Amer J Epidem 93: 194–205, 1971.—Clinical effect, viremias and antibody responses were compared in horses inoculated with the following strains of Venezuelan equine encephalomyelitis (VEE) virus: Fe3-7C, isolated from Culex (Melano-conion) spp. mosquitoes collected In 1963 in the Florida Everglades; TC-83, the Fort Detrick live, attenuated vaccine strain; and GJ9-1BJ, an isolate from Psorophora confinnis mosquitoes collected in Guatemala during the 1969 epidemic of VEE. Six horses were inoculated with Fe3-7C, and, except for a febrile response of less than 24 hours' duration in one horse, no clinical responses were noted. Low-level viremias were detected in two horses. Six horses were also inoculated with TC-83. Five had a febrile response, and two of these horses were ill for two to three days. All of the TC-83 inoculated horses had detectable viremias, but the titers were low, i.e., <2.0 log10 SMICLD50/0.02 ml. Of four horses inoculated with GJ9-1BJ, all had a marked febrile response and high-titered viremias (3.5–5.5 log10 SMICLD50/0.02 ml) and one died. The 12 horses previously inoculated with Fe3-7C and TC-83 had neither clinical response nor viremia when challenged on the 34th and 28th days, respectively, with GJ9-1BJ. The pattern of development and persistence of hemagglutination inhibiting, complement fixing and neutralizing antibodies indicates that Fe3-7C antibodies are readily distinguishable from TC-83 and GJ9-1BJ antibodies, although there is cross-neutralization between all three virus strains.
Publication Date: 1971-03-01 PubMed ID: 4397564DOI: 10.1093/oxfordjournals.aje.a121246Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article details clinical and virological observations from a study where horses were experimentally infected with three different strains of Venezuelan equine encephalomyelitis (VEE) virus. The main findings were variations in clinical responses, viral levels, and antibody responses depending on the viral strain used.

Experimental Design

  • The study involved the use of three strains of Venezuelan equine encephalomyelitis (VEE) virus. These were the Fe3-7C strain, TC-83 strain, and the GJ9-1BJ strain. The different strains were inoculated into separate groups of horses and their reactions observed.
  • Researchers monitored the clinical effects (observable signs of disease), viremias (presence of viruses in the horse’s blood), and the horses’ antibody responses (the immune response to the virus).

Observations and Findings

  • In horses inoculated with the Fe3-7C strain, there were generally no observable clinical responses, bar one horse which displayed a mild fever for less than 24 hours. Low-level viremias were detected in two of the horses.
  • Horses injected with the TC-83 strain had a much higher clinical response rate. Five of them developed a fever, and two fell ill for a couple of days. All of them were found to have the virus in their blood, although the titers were low.
  • All horses infected with the GJ9-1BJ strain showed a significant feverish response. They all had high-titered viremias and one of them died.

Immune response to the Virus Strains

  • The horses previously inoculated with Fe3-7C and TC-83 strains did not react clinically or virologically when they were later infected with the GJ9-1BJ strain. This suggests that previous exposure to either strain confers some immunity against the GJ9-1BJ strain.
  • The antibody responses in horses also indicated differences based on the inoculation strain. While antibodies from the Fe3-7C strain were visibly different from those formed in response to TC-83 or GJ9-1BJ, there was some cross-neutralization amongst all three virus strains.

This study provides valuable insights into the clinical and virological responses horses have towards different VEE virus strains. Further studies could delve more into understanding the cross-neutralization between the different strains and how to leverage this towards creating a more effective vaccination approach.

Cite This Article

APA
Henderson BE, Chappell WA, Johnston JG, Sudia WD. (1971). Experimental infection of horses with three strains of Venezuelan equine encephalomyelitis virus. I. Clinical and virological studies. Am J Epidemiol, 93(3), 194-205. https://doi.org/10.1093/oxfordjournals.aje.a121246

Publication

ISSN: 0002-9262
NlmUniqueID: 7910653
Country: United States
Language: English
Volume: 93
Issue: 3
Pages: 194-205

Researcher Affiliations

Henderson, B E
    Chappell, W A
      Johnston, J G
        Sudia, W D

          MeSH Terms

          • Animals
          • Antibodies / analysis
          • Blood / microbiology
          • Complement Fixation Tests
          • Cross Reactions
          • Culicidae
          • Encephalitis Virus, Venezuelan Equine
          • Encephalitis Viruses / isolation & purification
          • Encephalitis, Arbovirus / epidemiology
          • Encephalitis, Arbovirus / immunology
          • Encephalitis, Arbovirus / microbiology
          • Encephalitis, Arbovirus / prevention & control
          • Fever
          • Hemagglutination Inhibition Tests
          • Horse Diseases / prevention & control
          • Horses
          • Immunization
          • Insect Vectors
          • Neutralization Tests
          • Species Specificity

          Citations

          This article has been cited 19 times.
          1. Yao Z, Zanini F, Kumar S, Karim M, Saul S, Bhalla N, Panpradist N, Muniz A, Narayanan A, Quake SR, Einav S. The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection. PLoS Negl Trop Dis 2021 Mar;15(3):e0009306.
            doi: 10.1371/journal.pntd.0009306pubmed: 33788849google scholar: lookup
          2. Chapman GE, Sherlock K, Hesson JC, Blagrove MSC, Lycett GJ, Archer D, Solomon T, Baylis M. Laboratory transmission potential of British mosquitoes for equine arboviruses. Parasit Vectors 2020 Aug 12;13(1):413.
            doi: 10.1186/s13071-020-04285-xpubmed: 32787904google scholar: lookup
          3. Atasheva S, Garmashova N, Frolov I, Frolova E. Venezuelan equine encephalitis virus capsid protein inhibits nuclear import in Mammalian but not in mosquito cells. J Virol 2008 Apr;82(8):4028-41.
            doi: 10.1128/JVI.02330-07pubmed: 18256144google scholar: lookup
          4. Garmashova N, Atasheva S, Kang W, Weaver SC, Frolova E, Frolov I. Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription. J Virol 2007 Dec;81(24):13552-65.
            doi: 10.1128/JVI.01576-07pubmed: 17913819google scholar: lookup
          5. Paessler S, Fayzulin RZ, Anishchenko M, Greene IP, Weaver SC, Frolov I. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J Virol 2003 Sep;77(17):9278-86.
          6. Gonzalez-Salazar D, Estrada-Franco JG, Carrara AS, Aronson JF, Weaver SC. Equine amplification and virulence of subtype IE Venezuelan equine encephalitis viruses isolated during the 1993 and 1996 Mexican epizootics. Emerg Infect Dis 2003 Feb;9(2):161-8.
            doi: 10.3201/eid0902.020124pubmed: 12603985google scholar: lookup
          7. Brault AC, Powers AM, Holmes EC, Woelk CH, Weaver SC. Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus. J Virol 2002 Feb;76(4):1718-30.
          8. Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994 Jan;7(1):89-116.
            doi: 10.1128/CMR.7.1.89pubmed: 8118792google scholar: lookup
          9. Dill GS Jr, Pederson CE Jr, Stookey JL. A comparison of the tissue lesions produced in adult hamsters by two strains of avirulent Venezuelan equine encephalomyelitis virus. Am J Pathol 1973 Jul;72(1):13-24.
            pubmed: 4719526
          10. Walton TE, Alvarez O Jr, Buckwalter RM, Johnson KM. Experimental infection of horses with an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Infect Immun 1972 May;5(5):750-6.
            doi: 10.1128/iai.5.5.750-756.1972pubmed: 4637604google scholar: lookup
          11. Eddy GA, Martin DH, Reeves WC, Johnson KM. Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Infect Immun 1972 Feb;5(2):160-3.
            doi: 10.1128/iai.5.2.160-163.1972pubmed: 4564397google scholar: lookup
          12. Walton TE, Johnson KM. Experimental Venezuelan equine encephalomyelitis virus infection of the bovine. Infect Immun 1972 Feb;5(2):155-9.
            doi: 10.1128/iai.5.2.155-159.1972pubmed: 4564396google scholar: lookup
          13. Pedersen CE Jr, Slocum DR, Robinson DM. Comparative studies of plaque variantes derived from a Florida strain of Venezuelan equine encephlomyelitis virus. Infect Immun 1972 Nov;6(5):779-84.
            doi: 10.1128/iai.6.5.779-784.1972pubmed: 4344368google scholar: lookup
          14. Calisher CH, Maness KC. Virulence of Venezuelan equine encephalomyelitis virus subtypes for various laboratory hosts. Appl Microbiol 1974 Nov;28(5):881-4.
            doi: 10.1128/am.28.5.881-884.1974pubmed: 4155263google scholar: lookup
          15. Kinney RM, Esposito JJ, Mathews JH, Johnson BJ, Roehrig JT, Barrett AD, Trent DW. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J Virol 1988 Dec;62(12):4697-702.
          16. Calisher CH, Maness KS. Laboratory studies of Venezuelan equine encephalitis virus in equines, Texas, 1971. J Clin Microbiol 1975 Sep;2(3):198-205.
            doi: 10.1128/jcm.2.3.198-205.1975pubmed: 1176627google scholar: lookup
          17. Scherer WF, Pancake BA. Comparisons of Venezuelan encephalitis virus strains by hemagglutination-inhibition tests with chicken antibodies. J Clin Microbiol 1977 Dec;6(6):578-85.
            doi: 10.1128/jcm.6.6.578-585.1977pubmed: 591629google scholar: lookup
          18. Burkett-Cadena ND, Fish D, Weaver S, Vittor AY. Everglades virus: an underrecognized disease-causing subtype of Venezuelan equine encephalitis virus endemic to Florida, USA. J Med Entomol 2023 Nov 14;60(6):1149-1164.
            doi: 10.1093/jme/tjad070pubmed: 37862065google scholar: lookup
          19. Mashin VV, Sergeev AN, Martynova NN, Sergeev AA, Lys'ko KA, Raikov AO, Kataeva VV, Zagidullin NV. Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum. Pharm Chem J 2022;56(4):532-537.
            doi: 10.1007/s11094-022-02675-2pubmed: 35845147google scholar: lookup